Special considerations in the management of patients with myelodysplastic myndrome / myeloproliferative neoplasm overlap syndromes during the SARS-CoV-2 pandemic

Am J Hematol. 2020 Aug;95(8):E203-E208. doi: 10.1002/ajh.25853. Epub 2020 May 22.

¹ Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
² Malignant Hematology, Moffitt Cancer Center, Tampa, Florida, USA.
³ Section of Hematology, Department of Internal Medicine , School of Medicine, Yale University and Yale Cancer Center, New Haven, Conneticut, USA.
⁴ Department of Internal Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
⁵ Adult Leukemia Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusets, USA.
⁶ Department of Hematology, Institute Gustave Roussy, Paris, France.

No abstract available

Publication types